Lupin buys Dutch sterile injectable manufacturer Nanomi; Clearside Biomedical patents microneedle eye drug delivery;

> India's Lupin bought Dutch sterile injectable manufacturer Nanomi for an undisclosed amount. More from FiercePharmaManufacturing

> Clearside Biomedical snagged a patent for its microneedle drug delivery to the eye. More

> Intellipharmaceutics collected $3.1 million from Par Pharmaceuticals for its dexmethylphenidate hydrochloride extended-release capsules. More

> Analysts predict the microfluidics market will reach $3.5 billion by 2018, rising about 17% from $1.59 billion in 2013. Release

> Aegis collected a patent for the oral delivery of nucleotide-based drugs. Release

Suggested Articles

The new digital Abilify is a breakthrough for Proteus Digital Health and its patient-tracking products, but not so much for Abilify's maker, Otsuka.

Adamis Pharmaceuticals' EpiPen contender Symjepi, which was rejected last year before the EpiPen havoc, won approval from the FDA.

Researchers in the U.K. have developed a technique to better predict results in liver cancer when drug-laden polymer beads are used to deliver medicines.